These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37166552)

  • 1. Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV.
    Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):169-182. PubMed ID: 37166552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
    Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
    J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
    Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
    Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.
    Barco A; Orlando S; Stroffolini G; Pirriatore V; Lazzaro A; Vai D; Guastamacchia G; Noce G; Atzori C; Trunfio M; Bonora S; Di Perri G; Calcagno A
    J Neurovirol; 2022 Apr; 28(2):226-235. PubMed ID: 35044644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation.
    Lupia T; Milia MG; Atzori C; Gianella S; Audagnotto S; Imperiale D; Mighetto L; Pirriatore V; Gregori G; Lipani F; Ghisetti V; Bonora S; Di Perri G; Calcagno A
    AIDS; 2020 Mar; 34(3):373-380. PubMed ID: 31764071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
    Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
    J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
    Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
    Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV.
    Trunfio M; Sacchi A; Vai D; Pittaluga F; Croce M; Cavallo R; Imperiale D; Bonora S; Di Perri G; Letendre SL; Calcagno A
    AIDS; 2024 Mar; 38(4):477-486. PubMed ID: 37939156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia.
    Motta I; Allice T; Romito A; Ferrara M; Ecclesia S; Imperiale D; Ghisetti V; Di Perri G; Bonora S; Calcagno A
    Antivir Ther; 2017; 22(6):539-543. PubMed ID: 28198350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
    Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
    JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.
    Pilz G; Sakic I; Wipfler P; Kraus J; Haschke-Becher E; Hitzl W; Trinka E; Harrer A
    Fluids Barriers CNS; 2020 Feb; 17(1):7. PubMed ID: 32089130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
    Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM; Price RW
    J Infect Dis; 2011 Sep; 204(5):753-60. PubMed ID: 21844301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
    Sinclair E; Ronquillo R; Lollo N; Deeks SG; Hunt P; Yiannoutsos CT; Spudich S; Price RW
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):544-52. PubMed ID: 18362693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.
    Wang SX; Ho EL; Grill M; Lee E; Peterson J; Robertson K; Fuchs D; Sinclair E; Price RW; Spudich S
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):303-10. PubMed ID: 24732871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels.
    Andersson LM; Hagberg L; Fuchs D; Svennerholm B; Gisslén M
    J Neurovirol; 2001 Dec; 7(6):542-7. PubMed ID: 11704886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has CXCL13 an added value in diagnosis of neurosyphilis?
    Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
    J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition.
    Trunfio M; Atzori C; Pasquero M; Di Stefano A; Vai D; Nigra M; Imperiale D; Bonora S; Di Perri G; Calcagno A
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
    Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.